HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.

AbstractOBJECTIVE:
To determine the prevalence of autoantibodies directed against an epitope of the glutamate/N-methyl-D-aspartic acid (NMDA) receptor subunit NR2A (which is highly expressed in human brain) in the sera of lupus patients, and to investigate the possible correlation of these antibodies with clinical and serological manifestations of systemic lupus erythematosus (SLE).
METHODS:
Sera were obtained from 109 consecutive SLE patients. Controls were 65 patients with myasthenia gravis, 19 with autoimmune polyendocrine syndrome type I (APS I), and 65 healthy donors. A 15 amino acid long peptide based on a sequence within the NR2A subunit of the NMDA/glutamate receptor was synthesised. Antibodies to this peptide were determined by enzyme linked immunosorbent assay. Antibodies against double stranded DNA (dsDNA) were measured by Chrithidia luciliae assay. Disease activity was determined using the SLE disease activity index (SLEDAI).
RESULTS:
Sera of 34/109 SLE patients (31%) reacted specifically with the NR2A peptide compared with only 4/65 myasthenia gravis patients (6.1%, p<0.001), 1/19 APS I patients (5.3%, p<0.02), and 3/65 healthy controls (4.6%, p<0.001). No correlation was found between the presence of NR2A and dsDNA or anti-cardiolipin specific autoantibodies. In addition, no significant correlation was observed between the presence of NR2A specific antibodies and the SLEDAI score or any lupus related clinical manifestations.
CONCLUSIONS:
A significant number of SLE patients (31%) have NR2A specific antibodies that do not correlate with anti-dsDNA antibodies. Additional studies of lupus patients with neurological disorders should elucidate the role of NR2A specific antibodies in lupus related CNS manifestations.
AuthorsE S Husebye, Z M Sthoeger, M Dayan, H Zinger, D Elbirt, M Levite, E Mozes
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 64 Issue 8 Pg. 1210-3 (Aug 2005) ISSN: 0003-4967 [Print] England
PMID15708887 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antinuclear
  • Autoantibodies
  • NR2A NMDA receptor
  • Receptors, N-Methyl-D-Aspartate
  • DNA
Topics
  • Adult
  • Antibodies, Antinuclear (blood)
  • Autoantibodies (blood)
  • DNA (immunology)
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Female
  • Humans
  • Lupus Erythematosus, Systemic (immunology)
  • Male
  • Middle Aged
  • Myasthenia Gravis (immunology)
  • Polyendocrinopathies, Autoimmune (immunology)
  • Receptors, N-Methyl-D-Aspartate (immunology)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: